Search

Items tagged with: Immunotherapy


Cancer immunotherapy market set to reach $311.4B by 2031, more than doubling from $144.8B in 2025. Strong research pipelines and supportive regulations driving growth. #Immunotherapy #Oncology


New study of 6,000+ patients suggests earlier timing of immune checkpoint inhibitor therapy improves survival in advanced solid tumors. JAMA Network Open findings could reshape cancer treatment protocols. #Oncology #Immunotherapy


GeoVax advances Gedeptin, a gene therapy designed to enhance checkpoint inhibitor response in immunologically cold tumors. Planned neoadjuvant study in head and neck cancer could expand combination immunotherapy options. #Oncology #Immunotherapy

This website uses cookies to recognize revisiting and logged in users. You accept the usage of these cookies by continue browsing this website.